info@quantimol.com - 1 (800) 821-7314 - Research Use Only - B2B & B2G Only - Not For Private Use
SKU:QM-0137103-01
Couldn't load pickup availability
Y06137 is a potent and selective BET inhibitor for treatment of castration-resistant prostate cancer (CRPC) . Y06137 binds to the BRD4 (1) bromodomain with a Kd of 81 nM[1].
[2226534-49-0]
C27H32N4O2
444.57
CC1=NOC(C1=C2)=CC=C2C3=NC(C=C4)=C(N3CC5CCCCC5)C=C4N6CCOC[C@@H]6C
Epigenetic Reader Domain
BRD4
99.9
DMSO : 62.5 mg/mL (ultrasonic)
-20°C, 3 years; 4°C, 2 years (Powder)
Room Temperature
Loading...
Total items
Product subtotal
Y06137 is a premium-grade research compound supplied by Quantimol for laboratory and scientific applications.